Refractive changes after two years accelerated corneal cross-linking in patients with keratoconus

dc.contributorMora, Matilde
dc.contributormora
dc.creatorRosenstiehl, Shirley
dc.creatorMora, Matilde
dc.creatorRios, Hernán Andres
dc.creatorLonngi, Marcela
dc.date.accessioned2019-02-04T15:19:00Z
dc.date.available2019-02-04T15:19:00Z
dc.date.created2019-02-04T15:19:00Z
dc.date.issued2018
dc.identifierhttp://repository.urosario.edu.co/handle/10336/18999
dc.identifierhttps://doi.org/10.48713/10336_18999
dc.description.abstractPurpose: To describe the visual and topographical changes after accelerated corneal collagen cross-linking (ACXL) in keratoconus-affected eyes. Methods: Clinical records of patients with keratoconus-affected eyes that underwent ACXL treatment and had 24 months of follow-up were reviewed. Data regarding demographics, visual acuity (VA), refraction and Sheimpflug values before and post ACXL were analyzed. We included patients with keratoconus older than 12 years old, with corneal thickness greater than 400 microns and steepest keratometry <60 diopters by Sheimpflug (Pentacam), with reported uncorrected distant visual acuity (UDVA), manifest refraction and best-corrected visual acuity (BCVA) evaluation pre ACXL and 24 months after surgery. The exclusion criteria were: history of ocular trauma, anterior segment surgery, retinal detachment or any type of maculopathy. Results: 21 eyes were included. Mean age was 27 years. Mean uncorrected distant VA (UDVA) before the procedure was 1.01 logMAR (20/200 Snellen) and after 24 months improved significantly to 0.62 logMAR (20/83 Snellen) with a p value of 0.005. No statistical significant difference was found between preoperative and postoperative refractive, keratometric and pachymetric data. Induced astigmatism value was -1.11 D (range 0.13 D – 2.28 D). Conclusions: ACXL is a technique to prevent the progression of keratoconus, however refractive and VA changes could be expected after procedure. The observed changes must be considered when performing the procedure together with refractive surgery.
dc.languagespa
dc.publisherUniversidad del Rosario
dc.publisherEspecialización en Oftalmología
dc.publisherFacultad de Medicina
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightsAbierto (Texto Completo)
dc.rightsEL AUTOR, manifiesta que la obra objeto de la presente autorización es original y la realizó sin violar o usurpar derechos de autor de terceros, por lo tanto la obra es de exclusiva autoría y tiene la titularidad sobre la misma. PARGRAFO: En caso de presentarse cualquier reclamación o acción por parte de un tercero en cuanto a los derechos de autor sobre la obra en cuestión, EL AUTOR, asumirá toda la responsabilidad, y saldrá en defensa de los derechos aquí autorizados; para todos los efectos la universidad actúa como un tercero de buena fe. EL AUTOR, autoriza a LA UNIVERSIDAD DEL ROSARIO, para que en los términos establecidos en la Ley 23 de 1982, Ley 44 de 1993, Decisión andina 351 de 1993, Decreto 460 de 1995 y demás normas generales sobre la materia, utilice y use la obra objeto de la presente autorización. -------------------------------------- POLITICA DE TRATAMIENTO DE DATOS PERSONALES. Declaro que autorizo previa y de forma informada el tratamiento de mis datos personales por parte de LA UNIVERSIDAD DEL ROSARIO para fines académicos y en aplicación de convenios con terceros o servicios conexos con actividades propias de la academia, con estricto cumplimiento de los principios de ley. Para el correcto ejercicio de mi derecho de habeas data cuento con la cuenta de correo habeasdata@urosario.edu.co, donde previa identificación podré solicitar la consulta, corrección y supresión de mis datos.
dc.sourceChan E, Snibson GR. Current status of corneal collagen cross-linking for keratoconus: A review. Clin Exp Optom 2013; 96(2):155–64.
dc.sourceKanellopoulos AJ. Long term results of a prospective randomized bilateral eye comparison trial of higher fluence, shorter duration ultraviolet A radiation, and riboflavin collagen cross linking for progressive keratoconus. Clin Ophthalmol 2012; 6(1):97–101.
dc.sourceAndreassen TT, Simonsen AH, Oxlund H. Biomechanical properties of keratoconus and normal corneas. Exp Eye Res 1980; 31(4):435–41.
dc.sourceSung H-W, Chang W-H, Ma C-Y, Lee M-H. Crosslinking of biological tissues using genipin and/or carbodiimide. J Biomed Mater Res A 2003; 64(3):427–38.
dc.sourceWollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol 2003; 135(5):620–627.
dc.sourceMazzotta C, Balestrazzi A, Traversi C, Baiocchi S, Caporossi T, Tommasi C, et al. Treatment of progressive keratoconus by riboflavin-UVA-induced cross-linking of corneal collagen: ultrastructural analysis by Heidelberg Retinal Tomograph II in vivo confocal microscopy in humans. Cornea 2007; 26(4):390–397.
dc.sourceWollensak G, Spörl E, Reber F, Pillunat L, Funk R. Corneal endothelial cytotoxicity of riboflavin/UVA treatment in vitro. Ophthalmic Res 2003; 35(6):324–328.
dc.sourceWollensak G, Spörl E, Reber F, Pillunat L, Funk R. Corneal endothelial cytotoxicity of riboflavin/UVA treatment in vitro. Ophthalmic Res 2003; 35(6):324–328.
dc.sourceWollensak G, Spoerl E, Wilsch M, Seiler T. Endothelial cell damage after riboflavin-ultraviolet-A treatment in the rabbit. J Cataract Refract Surg 2003; 29(9):1786–1790.
dc.sourceLegare ME, Iovieno A, Yeung SN, Kim P, Lichtinger A, Hollands S, et al. Corneal collagen cross-linking using riboflavin and ultraviolet A for the treatment of mild to moderate keratoconus: 2-year follow-up. Can J Ophthalmol 2013; 48(1):63–68.
dc.sourceHashemi H, Seyedian MA, Miraftab M, Fotouhi A, Asgari S. Corneal collagen cross-linking with riboflavin and ultraviolet a irradiation for keratoconus: long-term results. Ophthalmology 2013; 120(8):1515–1520.
dc.sourceGatzioufas Z, Richoz O, Brugnoli E, Hafezi F. Safety profile of high-fluence corneal collagen cross-linking for progressive keratoconus: preliminary results from a prospective cohort study. J Refract Surg 2013; 29(12):846–848.
dc.sourceCınar Y, Cingü AK, Türkcü FM, Cınar T, Yüksel H, Ozkurt ZG, et al. Comparison of accelerated and conventional corneal collagen cross-linking for progressive keratoconus. Cutan Ocul Toxicol 2013; 9527:1–5.
dc.sourceCınar Y, Cingü AK, Turkcu FM, Yüksel H, Sahin A, Yıldırım A, et al. Accelerated corneal collagen cross-linking for progressive keratoconus. Cutan Ocul Toxicol 2014; 33(2):168–171.
dc.sourceKymionis GD, Portaliou DM, Kounis GA, Limnopoulou AN, Kontadakis GA, Grentzelos MA. Simultaneous Topography-Guided Photorefractive Keratectomy Followed by Corneal Collagen Cross-linking for Keratoconus. Am J Ophthalmol 2011; 152(5):748–755.
dc.sourceElbaz U, Shen C, Lichtinger A, Zauberman N a, Goldich Y, Chan CC, et al. Accelerated ( 9-mW / cm 2 ) Corneal Collagen Crosslinking for Keratoconus- A 1-Year Follow-up. Cornea 2014; 33(8):769-773.
dc.sourceThibos LN, Wheeler W, Horner D. Power vectors: an application of Fourier analysis to the description and statistical analysis of refractive error. Optom Vis Sci 1997; 74(6):367–375.
dc.sourceMarino GK, Torricelli AA, Giacomin N, Santhiago MR, Espindola R, Netto M V. Accelerated Corneal Collagen Cross-linking for Postoperative LASIK Ectasia: Two-Year Outcomes. J Refract Surg 2015; 31(6):380–384.
dc.sourceKymionis GD, Grentzelos MA, Kankariya VP, Liakopoulos DA, Portaliou DM, Tsoulnaras KI, et al. Safety of highintensity corneal collagen crosslinking. J Cataract Refract Surg 2014; 40(8):1337–1340.
dc.sourceVinciguerra R, Romano MR, Camesasca FI, Azzolini C, Trazza S, Morenghi E, et al. Corneal cross-linking as a treatment for keratoconus: four-year morphologic and clinical outcomes with respect to patient age. Ophthalmology 2013; 120(5):908–916.
dc.sourceCagil N, Sarac O, Cakmak HB, Can G, Can E. Mechanical epithelial removal followed by corneal collagen crosslinking in progressive keratoconus: Short-term complications. J Cataract Refract Surg 2015; 41(8):1730–1737.
dc.sourceGreenstein SA, Fry KL, Bhatt J, Hersh PS. Natural history of corneal haze after collagen crosslinking for keratoconus and corneal ectasia: Scheimpflug and biomicroscopic analysis. J Cataract Refract Surg 2010; 36(12):2105–2114.
dc.sourceGreenstein SA, Hersh PS. Characteristics influencing outcomes of corneal collagen crosslinking for keratoconus and ectasia: implications for patient selection. J Cataract Refract Surg 2013; 39(8):1133–1140.
dc.sourceKoppen C, Wouters K, Mathysen D, Rozema J, Tassignon M-J. Refractive and topographic results of benzalkonium chloride-assisted transepithelial crosslinking. J Cataract Refract Surg 2012; 38(6):1000–1005.
dc.sourceMcAnena L, O’Keefe M. Corneal collagen crosslinking in children with keratoconus. J AAPOS 2015; 19(3):228–232.
dc.sourceViswanathan D, Kumar NL, Males JJ. Outcome of corneal collagen crosslinking for progressive keratoconus in paediatric patients. Biomed Res Int 2014;2014:140461.
dc.sourceBuzzonetti L, Petrocelli G. Transepithelial corneal cross-linking in pediatric patients: early results. J Refract Surg 2012;28:763–767
dc.sourceRitu Arora, Parul Jain, J. L. Goyal, Deepa Gupta. Comparative Analysis of Refractive and Topographic Changes in Early and Advanced Keratoconic Eyes Undergoing Corneal Collagen Crosslinking. Cornea. 2013 Oct; 32(10): 13591364.
dc.sourceinstname:Universidad del Rosario
dc.sourcereponame:Repositorio Institucional EdocUR
dc.subjectCollagen cross-linking
dc.subjectRefractive changes
dc.subjectInduced astigmatism
dc.titleRefractive changes after two years accelerated corneal cross-linking in patients with keratoconus
dc.typemasterThesis


Este ítem pertenece a la siguiente institución